The effect of polymorphism on powder compaction and dissolution propertiesof chemically equivalent oxytetracycline hydrochloride powders

Citation
W. Liebenberg et al., The effect of polymorphism on powder compaction and dissolution propertiesof chemically equivalent oxytetracycline hydrochloride powders, DRUG DEV IN, 25(9), 1999, pp. 1027-1033
Citations number
12
Categorie Soggetti
Pharmacology & Toxicology
Journal title
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
ISSN journal
03639045 → ACNP
Volume
25
Issue
9
Year of publication
1999
Pages
1027 - 1033
Database
ISI
SICI code
0363-9045(1999)25:9<1027:TEOPOP>2.0.ZU;2-4
Abstract
In South Africa, oxytetracycline is identified as an essential drug; many g eneric products are on the market, and many more are being developed In thi s study, six oxytetracycline hydrochloride powders were obtained randomly f rom manufacturers, and suppliers were compared. It was found that complianc e to a pharmacopoeial monograph was insufficient to ensure the optimum diss olution performance of a simple tablet formulation. Comparative physicochem ical raw material analysis showed no major differences with regard to diffe rential scanning calorimetry (DSC), infrared (IR) spectroscopy, powder diss olution, and particle size. However, the samples could be divided into two distinct types with respect to X-ray powder diffraction (XRD) and thus poly morphism. The two polymorphic forms had different dissolution properties in water or 0.1 N hydrochloride acid. This difference became substantial when the dissolution from tablets was compared. The powders containing form A w ere less soluble than that containing form B.